A prognostic model to predict clinical outcomes with first-line gemcitabine-based chemotherapy in advanced pancreatic cancer.
Yi JH, Lee J, Park SH, Lee KT, Lee JK, Lee KH, Choi DW, Choi SH, Heo JS, Lim DH, Park YS, Lim HY, Kang WK, Park K, Park JO.
Yi JH, et al. Among authors: lim dh, lim hy.
Oncology. 2011;80(3-4):175-80. doi: 10.1159/000328449. Epub 2011 Jun 24.
Oncology. 2011.
PMID: 21701231